Midbrain dopaminergic neurons in the mouse: Computer-assisted mapping

Journal of Comparative Neurology

Volumn 369, Issue 3, 1996, Pages 361-371

  Nelson, E L ^a   Liang, C L ^b   Sinton, C M ^b   German, D C ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

immunohistochemical staining; retrorubral field; substantia nigra; tyrosine hydroxylase; ventral tegmental area

Indexed keywords

AMPHETAMINE; DOPAMINE RECEPTOR; LEVODOPA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; COMPUTER ANALYSIS; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; BRAIN MAPPING; CELL COUNT; DOPAMINE; IMAGE PROCESSING, COMPUTER-ASSISTED; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOSTRIATUM; NEURONS; TYROSINE 3-MONOOXYGENASE;

EID: 0029942834     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3     Document Type: Article

References (65)

1. Abercrombie, M. (1946) Estimation of nuclear population from microtome sections. Anat. Rec. 94:239-247.
2. Angrist, B. (1987) Pharmacological models of schizophrenia. In F.A. Henn and L.E. DeLisi (eds): Handbook of Schizophrenia, Vol. 2. Amsterdam: Elsevier, pp. 391-424.
3. Angrist, B., G. Sathananthan, S. Wilk, and S. Gershon (1974) Amphetamine psychosis: Behavioral and biochemical aspects. J. Psychiat. Res. 11:13-23.
4. Arsenault, M.-Y., A. Parent, P. Seguela, and L. Descarries (1988) Distribution and morphological characteristics of dopamine-immunoreactive neurons in the midbrain of the squirrel monkey (Saimiri sciureus). J. Comp. Neurol. 267:489-506.
5. Bak, I.J. (1967) The ultrastructure of the substantia nigra and caudate nucleus of the mouse - and the cellular localization of catecholamines. Exp. Brain Res. 3:40-57.
6. Baker, H., T.H. Joh, and D.J. Reis (1980) Genetic control of number of midbrain dopaminergic neurons in inbred strains of mice: Relationship to size and neuronal density of the striatum. Proc. Natl. Acad. Sci. USA 77:4369-4373.
7. Bentivoglio, M., D. van der Kooy, and H.G.J.M. Kuypers (1979) The organization of the efferent projections of the substantia nigra in the rat. A retrograde fluorescent double labeling study. Brain Res. 174:1-17.
8. Berger, B., C. Verney, C. Alvarez, A. Vigny, and K.B. Helle (1985) New dopaminergic terminal fields in the motor, visual (area 18b) and retrosplenial cortex in the young and adult rat. Immunocytochemical and catecholamine histochemical analyses. Neuroscience 15:983-998.
9. Bogerts, B. (1981) A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker. J. Comp. Neurol. 197:63-80.
10. Bogerts, B., J. Hantsch, and M. Herzer (1983) A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol. Psychiat. 18:951-969.
11. Carlsson, A. (1978) Antipsychotic drugs, neurotransmitters and schizophrenia. Am. J. Psychiatry 135:164-173.
12. Creese, I., D.R. Burt, and S.H. Snyder (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483.
13. Dahlstrom, A., and K. Fuxe (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. Suppl. 232:1-55.
14. Davis, J.M., and D.S. Janowsky (1973) Amphetamine and methylphenidate psychosis. In E. Usdin and S.H. Snyder (eds.): Frontiers of Catecholamine Research. New York: Pergamon Press, pp. 977-981.
15. DiCarlo, V., J.E. Hubbard, and P. Pate (1973) Fluorescence histochemistry of monoamine-containing cell bodies in the brain stem of the squirrel monkey (Saimiri sciureus). J. Comp. Neurol. 125:347-372.
16. Fallon, J., and R.Y. Moore (1978) Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180:545-580.
17. Francois, C., G. Percheron, and J. Yelnik (1984) Localization of nigrostriatal, nigrothalamic and nigrotectal neurons in ventricular coordinates in macaques. Neuroscience 13:61-76.
18. Gerfen, C.R., W.A. Staines, G.W. Arbuthnott, and H.C. Fibiger (1982) Crossed connections of the substantia nigra in the rat. J. Comp. Neurol. 207:283-303.
19. Gerfen, C.R., M. Herkenham, and J. Thibault (1987) The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. Neuroscience 7:3915-3934.
20. German, D.C., and K.F. Manaye (1993) Midbrain dopaminergic neurons (nuclei A8, A9 and A10): Three-dimensional reconstruction in the rat. J. Comp. Neurol. 331:297-309.
21. German, D.C., D.S. Schlusselberg, and D.J. Woodward (1983) Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: From mouse to man. J. Neural Trans. 57:243-254.
22. German, D.C., M. Dubach, S. Askari, S.G. Speciale, and D.M. Bowden (1988) 1-Methyl-4-phenyl-1, 2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: Which midbrain dopaminergic neurons are lost? Neuroscience 24:161-174.
23. German, D.C., K.F. Manaye, W.K. Smith, D.J. Woodward, and C.B. Saper (1989) Midbrain dopaminergic cell loss in Parkinson's disease: Computer visualization. Ann Neurol. 26:507-514.
24. 28k-containing cells. Ann. New York Acad. Sci. 648:42-62.
25. Graham, D.C. (1979) On the origin and significance of neuromelanin. Arch. Pathol. Lab. 103:359-362.
26. Gulley, R.L., and R.L. Wood (1971) The fine structure of the neurons in the rat substantia nigra. Tissue Cell 3:675-690.
27. Hajdu, F., R. Hassler, and I.J. Bak (1973) Electron microscopic study of the substantia nigra and the strio-nigral projection in the rat. Z. Zellforsch 146:207-221.
28. Halliday, G.M., and I. Tork (1986) Comparative anatomy of the ventrome-dial mesencephalic tegmentum in the rat, cat, monkey and human. J. Comp. Neurol. 252:423-445.
29. Mailman, H., J. Lange, L. Olson, I. Stromberg, and G. Jonsson (1985) Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse. J. Neurochem. 44:117-127.
30. Hassler, R. (1939) Zur pathologischen anatomie des senilen und des parkinsonistichen tremor. J. Psychol. Neurol. 49:13-55.
31. Heikkila, R.E., A. Hess, and R.C. Duvoisin (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224:1451-1453.
32. Helmeste, D.M., and P. Seeman (1982) Amphetamine-induced hypolocomotion in mice with more brain D2 dopamine receptors. Psychiat. Res. 7:351-359.
33. Hökfelt, T., R. Martensson, A. Björklund, S. Kleinau, and M. Goldstein (1984) Distributional maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. In A. Björklund and T. Hökfelt (eds): Handbook of Chemical Neuroanatomy, Vol. 2. New York: Elsevier Press, pp. 277-379.
34. Hornykiewicz, O. (1979) Brain dopamine in Parkinson's disease and other neurological disturbances. In A.S. Horn, J. Korf, and B.H.C. Westerink (eds): The Neurobiology of Dopamine. New York: Academic Press, pp. 633-654.
35. Jacobowitz, D.M., and M. Palkovits (1974) Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. 1. Forebrain (telencephalon, diencephalon). J. Comp. Neurol. 157:13-28.
36. Jimenez-Castellanos, J., and A.M. Graybiel (1987) Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience 23:223-242.
37. Juraska, J.M., C.J. Wilson, and P.M. Groves (1977) The substantia nigra of the rat: A Golgi study. J. Comp. Neurol. 172:585-600.
38. Konigsmark, B.W. (1970) Methods for the counting of neurons. In W.J.H. Nauta and S.O.E. Ebbeson (eds): Contemporary Research Method in Neuroanatomy. New York: Springer, pp. 315-380.
39. Lavoie, B., and A. Parent (1991) Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. NeuroReport 2:601-604.
40. Lindvall, O., and A. Björklund (1974) The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol. Scand. [Suppl] 412:1-48.
41. Lynd-Balta, E., and S.N. Haber (1994) The organization of midbrain projections to the ventral striatum in the primate. Neuroscience 59:609-623.
42. McGeer, P.L., E.G. McGeer, and J.S. Suzuki (1977) Aging and extrapyramidal functions. Arch. Neurol. 34:33-35.
43. Moisset, B. (1977) Genetic analysis of the behavioral response to damphetamine in mice. Psychopharmacology 53:263-267.
44. Olszewski, J., and O. Baxter (1954) Cytoarchitecture of the Human Brain Stem. Basel: Karger.
45. Pakkenberg, B., A. Moller, H.J.G. Gundersen, A. Mouritzen Dam, and H. Pakkenberg (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.
46. Parent, A., A. Mackey, and L. De Bellefeuille (1983) The subcortical afferents to caudate nucleus and putamen in primate: A fluorescence retrograde double labeling study. Neuroscience 10:1137-1150.
47. Paxinos, G., and C. Watson (1986) The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
48. Pearson, J., M. Goldstein, K. Markey, and L. Brandeis (1983) Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscienee 8:3-32.
49. Phillipson, O.T. (1979) The cytoarchitecture of the interfascicular nucleus and ventral tegmental area of Tsai in the rat. J. Comp. Neurol. 187:85-98.
50. Pickel, V.M., T.H. Joh, P.M. Field, C.G. Becker, and D. J. Reis (1975) Cellular localization of tyrosine hydroxylase in brain by light and electron microscopy. Brain Res. 85:295-300.
51. Poirier, L.J., M. Giguere, and R. Marchand (1983) Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat. Brain Res. Bull. 11:371-397.
52. Ramon y Cajal, S. (1995) Histology of the Nervous System. Vol. II. N. Swanson and L.W. Swanson (translators), New York: Oxford, p. 226.
53. Ross, R.A., A.B. Judd, V.M. Pickel, T.H. Joh, and D.J. Reis (1976) Strain-dependent variations in number of midbrain dopaminergic neurons. Nature 264:654-656.
54. Saper, C.B., and C.K. Petito (1982) Correspondence of melanin-pigmented neurons in the human brain with A1-A14 catecholamine cell groups. Brain 105:87-102.
55. Scatton, B., F. Javoy-Agid, and L. Rouquier (1983) Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res. 275:321-328.
56. Schwyn, R.C., and C.A. Fox (1974) The primate substantia nigra: A golgi and electron microscopic study. J. Hirnforsch 15:95-126.
57. Seeman, P., T. Lee, M. Chau-Wong, and K. Wong (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, Lond. 261:717-119.
58. Seniuk, N.A., W.G. Tatton, and C.E. Greenwood (1990) Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP. Brain Res. 527:7-20.
59. Snyder, S.H. (1972) Catecholamines in the brain as mediators of amphetamine psychosis. Arch. Gen. Psychiat. 27:169-179.
60. Swanson, L.W. (1982) The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9:321-353.
61. Szabo, J. (1980) Organization of the ascending striatal afferents in monkeys. J. Comp. Neurol. 189:307-321.
62. Taketo, M., A.C Schroeder, L.E. Mobraaten, K.B. Gunning, G. Hanten, R.R. Fox, T.H. Roderick, C.L. Stewart, F. Lilly, C.T. Hansen, and P.A. Overbeek (1991) FVB/N: An inbred mouse strain preferable for transgenic analyses. Proc. Natl. Acad. Sci. 88:2065-2069.
63. Tomac, A., E. Lindqvist, L.-F.H. Lin, S.O. Ogren, D. Young, B.J. Hoffer, and L. Olson (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335-339.
64. Triarhou, L.C., J. Norton, and B. Ghetti (1988) Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice. Exp. Brain Res. 70:256-265.
65. Ungerstedt, U. (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand. [Suppl] 367:1-48.